Periodic Reporting for period 1 - NUTRIclock (NUTRIclock: a tool based on microbiome and artificial intelligence for implementing precision nutrition.)
Période du rapport: 2023-06-01 au 2025-09-30
Next, different architectures and combinations of data were tested to obtain the best balance between age prediction and performance of the algorithm. The following architectures were used: I) Multilayer perceptron NN (MLPNN), a classical NN approach with hidden layers extracting information from input data. II) Convolutional NN (CNN), specific for images treatment. III) Variational autoencoders (VAE), architectures that extract information of the input data generating a latent representation that might be used to reconstruct the original data. These architectures were used on microbiome relative abundances, inferred metabolites relative abundances and/or metabolites-related pathway abundances. The architecture with the better prediction/performance balance was a CNN + VAE on microbiome data combined with MLPNN + VAE on inferred metabolites data.
Finally, the NUTRIclock algorithm was tested on samples from a diseased population and from a nutritional intervention study. I) The algorithm showed increased prediction of biological age in patients with age-related diseases like diabetes and cancer. This was the expected result, whereas they are considered “older”, and confirmed that the algorithm works. The effect was particularly increasing with the severity of the conditions. II) When applied to a nutritional intervention study in overweight/obese patients, it showed a discreet rise in biological age for non-responders and no changes for responders, aligning with previous results given the short duration of the intervention (3 weeks) and mild responder criteria (only 2kg weight loss).
Nevertheless, the MSC action allowed me to grow as an independent researcher and had great impact on my scientific career at different levels: I) Receiving training in NNs use and development together with leadership training, in prestigious courses from the MIT (Massachusetts), EMBO and ESADE business school. II) Collaborating and building an international network of partners, producing a review on the use of NNs on metagenomic data (corresponding authorship). III) Participating in international congresses with oral (ISMB Montreal 2024, Beneficial Microbes Conference 2025) and poster presentations (EFFOST Brugge 2024). IV) Mentoring my own master students, one of them currently my first PhD student. V) Being awarded with a renowned contract in Spain to become a fully independent PI (Ramón y Cajal contract).